Clinical Trial Update: Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the efficacy and safety of canakinumab for treating anemia in patients with lower-risk myelodysplastic syndromes. The study has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• Canakinumab (canakinumab)

Snippet

Sponsor: University of Leipzig | Conditions: Anemia, Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED